1000773-62-5

Basic information

• Product Name: 2-(BroMoMethyl)-5-(trifluoroMethyl)pyridine
• Synonyms: 2-(BroMoMethyl)-5-(trifluoroMethyl)pyridine
• CAS NO: 1000773-62-5
• Molecular Formula: C₇H₅BrF₃N
• Molecular Weight: 240.0205096
• Product Categories: Fluorine series
• Mol File: 1000773-62-5.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Store in freezer, under -20°C
• CAS DataBase Reference: 2-(BroMoMethyl)-5-(trifluoroMethyl)pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(BroMoMethyl)-5-(trifluoroMethyl)pyridine(1000773-62-5)
• EPA Substance Registry System: 2-(BroMoMethyl)-5-(trifluoroMethyl)pyridine(1000773-62-5)

Safety Data

• Hazardous Substances Data: 1000773-62-5(Hazardous Substances Data)

Usage

General Description

2-(BromoMethyl)-5-(trifluoroMethyl)pyridine is a chemical compound with the molecular formula C8H7BrF3N. It is a pyridine derivative that contains a bromine and trifluoromethyl group. 2-(BroMoMethyl)-5-(trifluoroMethyl)pyridine is commonly used in organic synthesis and pharmaceutical research. It has potential applications in the development of new drugs and as an intermediate in the production of various chemicals. 2-(BromoMethyl)-5-(trifluoroMethyl)pyridine is a colorless to light yellow liquid with a strong odor. It should be handled and stored with care due to its potential hazards and reactivity.

Upstream product

• 124236-37-9 5-(trifluoromethyl)-pyridine-2-carboxylic acid methyl ester 
• 31181-84-7 2-hydroxymethyl-5-trifluoromethylpyridine 
• 100366-75-4 2‐iodo‐5‐(trifluoromethyl)pyridine 

Downstream Products

• 1227473-73-5 tert-butyl (3R)-3-(4-([5-(trifluoromethyl)pyridin-2-yl]methoxy)phenyl)-1-oxa-8-azaspiro[4.5]decane-8-carboxylate 

Relevant articles and documents

COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

Described herein are compounds that act as CYP46A1 inhibitors, compositions comprising these compounds, and methods of their use into treating neurodegenerative diseases and the like, or a pharmaceutically active salt thereof. The present invention relates to compounds represented by the formula wherein each symbol is as defined in the specification, or a pharmaceutically active salt thereof.

NOVEL COMPOUNDS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein L, X, Ra, Rb, R1, R2 and R3 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.

PYRIDONE AND PYRIDAZINONE DERIVATIVES AS MCH ANTAGONISTS

The present invention relates to pyridone and pyridazinone derivatives as listed in claim 1 including their salts. Moreover the invention relates to pharmaceutical compositions containing at least one compound according to the invention. By virtue of thei